skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

 

OTC_Zantac_And_Private_Label


Sanofi's recall of OTC Zantac due to contamination of the active ingredient ranitidine with a potential carcinogenic is so widespread the US Food and Drug Administration's documentation of the firm's actions doesn't identify quantities of containers or packages but refers only to "all lots" of the products.

Information on some other firms' recalls for private label and store brand copies of OTC Zantac in 75- and 150-mg ranitidine formulations added to the FDA's recalls database between mid-December and 8 January also doesn't include amounts, which the agency's typically does in its recall records. Rather than identify all lots as the products covered in the recalls, the firms' information includes lists of dozens of serial numbers and other identifying data.

In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in the FDA's database updates for 11, 18 and 25 December and 2 and 8 January are Amneal Pharmaceuticals Inc, Preferred Pharmaceuticals Inc., which distributed products made by Amneal, and Granules India Ltd. (See table linked below.)

Ranitidine contamination and the FDA's response to the problem prompted Rep. Rosa DeLauro, D-CT, to ask that it keep the ingredient off the market and to re-introduced legislation proposing that the agency have mandatory recall authority for drugs.

おすすめのニュース&レポート

;

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。